Theravance Q1 earnings top estimates as collaboration revenues grow, while restructuring and cost cuts aim to drive $60-$70M ...
There is a moment most of us recognize but rarely discuss: the slow shuffle of a parent crossing a parking lot, or the way an ...
DNA damage from inflammation outpaces the cells’ ability to self-repair. The finding, in human brain cells and mice, could ...
Thousands of times per year, a family's moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or ...
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds ...
Growth strategy focus: Teva is evolving into a leading biopharma company by building on its generics base with innovative and biosimilar products. Pipeline milestones: Fast track designations, new ...